Invention Grant
- Patent Title: CEACAM1 based point-of-care cancer diagnostic
-
Application No.: US12265469Application Date: 2008-11-05
-
Publication No.: US10663464B2Publication Date: 2020-05-26
- Inventor: Gal Markel
- Applicant: Gal Markel
- Agency: McAndrews Held & Malloy, Ltd.
- Main IPC: G01N33/558
- IPC: G01N33/558 ; G01N33/574
Abstract:
The present technology regards the utilization of CEACAM1 as a biomarker for cancer. In particular the present invention regards the detection and measurement of soluble CEACAM1 levels for the detection and diagnosis of melanoma.
Public/Granted literature
- US20090181403A1 CEACAM1 Based Point-Of-Care Cancer Diagnostic Public/Granted day:2009-07-16
Information query
IPC分类:
